Home  

Random  

Nearby  



Log in  



Settings  



Donate  



About Wikipedia  

Disclaimers  



Wikipedia





Zaltoprofen





Article  

Talk  



Language  

Watch  

Edit  





Zaltoprofen (JAN; trade name Soleton) is a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent.[1] It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors.[2]

Zaltoprofen
Clinical data
Trade namesSoleton
Other namesZaxoprofen
Drug classNSAID
Legal status
Legal status
  • US: Not FDA approved
  • Japan: Rx-only
  • Identifiers
    • 2-(6-Oxo-5H-benzo[b][1]benzothiepin-3-yl)propanoic acid

    CAS Number
    PubChem CID
    DrugBank
    UNII
    CompTox Dashboard (EPA)
    ECHA InfoCard100.070.863 Edit this at Wikidata
    Chemical and physical data
    FormulaC17H14O3S
    Molar mass298.36 g·mol−1
    3D model (JSmol)
    • CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O

    It was approved for use in Japan in 1993.[3]

    References

    edit
    1. ^ "Zaltoprofen". drugs.com.
  • ^ Hirate K, Uchida A, Ogawa Y, Arai T, Yoda K (April 2006). "Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors". Neuroscience Research. 54 (4): 288–94. doi:10.1016/j.neures.2005.12.016. PMID 16473424. S2CID 27367042.
  • ^ "Zaltoprofen Launched in Japan". thepharmaletter.com. September 20, 1993.

  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Zaltoprofen&oldid=1205033063"
     



    Last edited on 8 February 2024, at 17:51  





    Languages

     


    فارسی

     

    Wikipedia


    This page was last edited on 8 February 2024, at 17:51 (UTC).

    Content is available under CC BY-SA 4.0 unless otherwise noted.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Terms of Use

    Desktop